Published Papers & Misc - FUJII Yasuhisa

41. Rossi SH, Tanaka H, Usher-Smith JA, Bernhard JC, Fujii Y, Stewart GD. . Kidney Cancer Screening and Epidemiology Société Internationale d’Urologie Journal.. 2022;

42. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

43. Kazunari Hara, Masanori Murakami, Yoshihiro Niitsu, Akira Takeuchi, Masato Horino, Kumiko Shiba, Kazutaka Tsujimoto, Chikara Komiya, Kenji Ikeda, Mika Tsuiki, Akiyo Tanabe, Toshihiro Tanaka, Minato Yokoyama, Yasuhisa Fujii, Mitsuhide Naruse, Tetsuya Yamada. Heterogeneous circulating miRNA profiles of PBMAH. Front Endocrinol (Lausanne). 2022; 13 1073328. ( PubMed, DOI )

44. Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study Diagnostics (Basel). 2021.12;

45. Soichiro Yoshida, Yasuhisa Fujii. MRI-Targeted Biopsy in Prostate Cancer Screening. N Engl J Med. 2021.11; 385 (22): 2110. ( PubMed, DOI )

46. Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hirotaka Akita, Shigeo Okuda, Yuki Iwaita, Kiyoko Mukai, Shunya Matsumoto, Ryo Ueda, Ryota Ishii, Ryuichi Mizuno, Yasuhisa Fujii, Mototsugu Oya, Masahiro Jinzaki. Diagnostic value of texture analysis of apparent diffusion coefficient maps for differentiating fat-poor angiomyolipoma from non-clear-cell renal cell carcinoma. Eur J Radiol. 2021.10; 143 109895. ( PubMed, DOI )

47. Riko Maruyama, Hiroshi Fukushima, Shohei Fukuda, Yosuke Yasuda, Sho Uehara, Hajime Tanaka, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. Int J Urol. 2021.10; 28 (10): 1032-1038. ( PubMed, DOI )

48. Minato Yokoyama, Junichiro Ishioka, Mikayo Toba, Hiroshi Fukushima, Hajime Tanaka, Soichiro Yoshida, Yoh Matsuoka, Masumi Ai, Kiyohide Fushimi, Yasuhisa Fujii. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018. Int J Urol. 2021.09; ( PubMed, DOI )

49. Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. Int J Urol. 2021.09; 28 (9): 920-926. ( PubMed, DOI )

50. Wataru Shimada, Hajime Tanaka, Yuki Fukawa, Koichiro Kimura, Kouhei Yamamoto, Shohei Fukuda, Hiroshi Fukushima, Yosuke Yasuda, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Ukihide Tateishi, Steven C Campbell, Yasuhisa Fujii. Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications. Int J Urol. 2021.08; ( PubMed, DOI )

51. Chiara Lonati, Philipp Baumeister, Luca Afferi, Andrea Mari, Andrea Minervini, Wojciech Krajewski, Sosan Azizi, Kees Hendricksen, Alberto Martini, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Alessandro Tafuri, Alessandro Antonelli, Maria Angela Cerruto, Morgan Rouprêt, Alexandra Masson-Lecomte, Ekaterina Laukhtina, David D'Andrea, Shahrokh F Shariat, Francesco Soria, Giancarlo Marra, Paolo Gontero, Roberto Contieri, Rodolfo Hurle, Anne Sophie Valiquette, M Carmen Mir, Stefania Zamboni, Claudio Simeone, Tobias Klatte, Jeremy Yuen-Chun Teoh, Soichiro Yoshida, Yasuhisa Fujii, Roberto Carando, Gerald B Schulz, Livio Mordasini, Agostino Mattei, Marco Moschini, . Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. Eur Urol Focus. 2021.08; ( PubMed, DOI )

52. Shimpei Yamamoto, Soichiro Yoshida, Chikako Ishii, Taro Takahara, Yuki Arita, Hiroshi Fukushima, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Yasuhisa Fujii. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. J Magn Reson Imaging. 2021.08; 54 (2): 401-408. ( PubMed, DOI )

53. Sunil H Patel, Ithaar H Derweesh, Kazutaka Saito, Dattatraya Patil, Margaret F Meagher, Ahmet Bindayi, Ahmed Eldefrawy, Devin N Patel, Ryan Nasseri, Yosuke Yasuda, Yasuhisa Fujii, Viraj A Master. Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC). Clin Genitourin Cancer. 2021.08; 19 (4): e206-e215. ( PubMed, DOI )

54. Masaki Kobayashi, Junichiro Ishioka, Yoh Matsuoka, Yuichi Fukuda, Yusuke Kohno, Keizo Kawano, Shinji Morimoto, Rie Muta, Motohiro Fujiwara, Naoko Kawamura, Tetsuo Okuno, Soichiro Yoshida, Minato Yokoyama, Rumi Suda, Ryota Saiki, Kenji Suzuki, Itsuo Kumazawa, Yasuhisa Fujii. Computer-aided diagnosis with a convolutional neural network algorithm for automated detection of urinary tract stones on plain X-ray. BMC Urol. 2021.08; 21 (1): 102. ( PubMed, DOI )

55. Soichiro Yoshida, Yoh Matsuoka, Kazuma Toda, Sho Uehara, Hajime Tanaka, Minato Yokoyama, Kazutaka Saito, Ryoichi Yoshimura, Yasuhisa Fujii. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU Case Rep. 2021.07; 4 (4): 228-230. ( PubMed, DOI )

56. Kazutaka Saito, Yoh Matsuoka, Kazuma Toda, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Kazunori Kihara, Yasuhisa Fujii. Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer. Brachytherapy. 2021.07; 20 (4): 842-848. ( PubMed, DOI )

57. Soichiro Yoshida, Yasuhisa Fujii. Editorial Comment to Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy. Int J Urol. 2021.07; 28 (7): 756. ( PubMed, DOI )

58. Koichiro Kimura, Soichiro Yoshida, Junichi Tsuchiya, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Ukihide Tateishi, Yasuhisa Fujii. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. Eur Radiol. 2021.06; ( PubMed, DOI )

59. Soichiro Yoshida, Taro Takahara, Yuki Arita, Kazuma Toda, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Yasuhisa Fujii. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy. Int Urol Nephrol. 2021.06; 53 (6): 1119-1125. ( PubMed, DOI )

60. Soichiro Yoshida, Taro Takahara, Yuki Arita, Shinjiro Sakaino, Kazuhiro Katahira, Yasuhisa Fujii. Whole-body diffusion-weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond. Int J Urol. 2021.05; 28 (5): 502-513. ( PubMed, DOI )